Genetic variations could predict ovarian cancer risk, survival prospectsApril 20th, 2009 - 3:18 pm ICT by ANI
Washington, Apr 20 (ANI): Genetic variations in the micro-RNA (miRNA) processing pathway genes and miRNA binding sites could predict a woman’s risk of developing ovarian cancer and her prospects for survival, according to a new study.
The study by researchers from The University of Texas M. D. Anderson Cancer Centre was the first to examine the association of genetic variants related to miRNA with ovarian cancer risk, overall survival for ovarian cancer patients, and platinum-based chemotherapy response.
“We found a gene dosage effect, the more unfavourable variations a woman has, the greater her ovarian cancer risk and the shorter her survival time,” said senior author Xifeng Wu, M.D., Ph.D., professor in M. D. Anderson’s Department of Epidemiology.
They found that median survival, for example, ranged from 151 months for women with fewest unfavourable variations to 24 months for those with the most.
It was also found that many of the variations indicated likely response to platinum-based chemotherapy.
“Our findings have the potential clinical application of indicating a patient’s prognosis and showing who will respond to different therapies by analysing a single blood sample. We also will incorporate this genetic information with epidemiological information to build a comprehensive model to predict susceptibility to ovarian cancer,” said Wu.
Researchers focussed on the miRNA-processing pathway because it is crucial to production of miRNAs, the small molecules that regulate between one third and half of all genes.
Also, they chose the binding sites on host genes where miRNAs exert their effects on gene expression.
The study examined genetic information from 417 cancer patients and 417 healthy controls.
For the study, they analysed 219 potential functional single nucleotide polymorphisms (SNPs) - variations of a single DNA building block in a gene - in eight genes that process miRNA and at the miRNA binding sites of 129 cancer-relevant genes.
And it was found that 12 SNPs were significantly linked with ovarian cancer risk.
Also, the risk of developing ovarian cancer was 4.5 times more in women with five or fewer unfavourable genotypes as compared to those with eight or more of these unfavourable genotypes.
Women with six to eight unfavourable SNPs were at twice the risk.
The team also found that 21 SNPs were significantly associated with overall survival.
The findings of the study were presented at the 100th annual meeting of the American Association for Cancer Research. (ANI)
- MicroRNAs could increase amputation risk in diabetics - Jan 13, 2011
- How ovarian cancer resists chemotherapy - Mar 03, 2011
- Scientists convert skin cells to stem cells more effieciently - Feb 03, 2011
- Gene makes ovarian cancer resistant to chemotherapy - Mar 03, 2011
- New discovery may help in the fight against ovarian cancer - Feb 04, 2011
- Genetic variation that cuts bladder cancer risk identified - Apr 03, 2011
- New genetic links to ovarian cancer risk discovered - Sep 20, 2010
- Micro-RNA that regulates insulin in obesity identified - Apr 01, 2011
- Blue light could be highly in potent platinum-based cancer treatment - Dec 10, 2010
- Scientists identify genetic predictors of oesophageal cancer - Nov 06, 2008
- Scientists uncover clues to cancer development in AIDS patients - Jun 18, 2009
- New experimental drug slows down growth of ovarian cancer - Apr 16, 2011
- Genetic variants that modify breast cancer risk identified - Sep 20, 2010
- New drug shows promise against platinum resistant ovarian cancer - Oct 10, 2010
- Why statins work for some people, but not for all - Apr 22, 2010
Tags: blood sample, cancer centre, cancer risk, chemotherapy, clinical application, epidemiological, gene expression, genetic information, genetic variants, genetic variations, host genes, m d anderson, median survival, mirna, nucleotide polymorphisms, ovarian cancer, ovarian cancer patients, prognosis, survival prospects, survival time